Bryce Istvan

Long/short equity, growth, biotech
Bryce Istvan
Long/short equity, growth, biotech
Contributor since: 2011
The Prostate Pipeline Revisited
Dryships Is Still A Long-Term Buy
PMT: A Different Style mREIT Now At An Attractive Entry-Point
The DryShips Disconnect